SCHEMBL15051607

SCHEMBL15051607

Cc1cnc(F)cc1-n1cc(C=O)c(-c2ccccc2Cl)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 2/20 0.34
HSD11B1 P28845 3/20 0.33
ERN1 O75460 1/20 0.33
ALDH1A1 P00352 3/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
PLA2G7 Q13093 2/20 0.32
POLB P06746 1/20 0.32
KMT2A Q03164 1/20 0.32
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31
TUBA3C P0DPH7 1/20 0.31
TUBA1B P68363 1/20 0.31
TUBA4A P68366 1/20 0.31
TUBB4B P68371 1/20 0.31
TUBB3 Q13509 1/20 0.31
TUBB2A Q13885 1/20 0.31
TUBB8 Q3ZCM7 1/20 0.31
TUBA3E Q6PEY2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15051327 0.80 POLB (0.38) HSD11B1ERN1ALDH1A1GLAGAA
SCHEMBL15050763 0.80 KCNN4 (0.34) KCNN4HSD11B1PLA2G7POLBKMT2A
SCHEMBL15051750 0.77 MC4R (0.36) KCNN4HSD11B1PLA2G7POLBKMT2A
SCHEMBL15051545 0.77 MAPT (0.43) ALDH1A1HPGDTUBB4ATUBBTUBA3C
SCHEMBL15051258 0.69 DGAT1 (0.33)
SCHEMBL15051386 0.68 JAK2 (0.51) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL15051695 0.67 GAA (0.41) ALDH1A1GAAHPGDPOLBKMT2A
SCHEMBL24086660 0.65 GRIA1 (0.37) ERN1ALDH1A1KMT2ALMNACYP1A2
SCHEMBL29957354 0.65 GRIA1 (0.37) ERN1ALDH1A1KMT2ALMNACYP1A2
SCHEMBL10041752 0.63 ERN1 (0.40) ERN1ALDH1A1GLAGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2793880-A1 HETEROARYLS AND USES THEREOF Millennium Pharmaceuticals, Inc. (US) 2014-10-29 EP disclosed
WO-2013096630-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 WO disclosed
WO-2013096630-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 WO disclosed
US-20130165464-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed
US-20130165464-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed
US-20130165464-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165464-A1 HETEROARYLS AND USES THEREOF PIK3C2B, PI4KB, PIK3R4 KCNN4 3877/4885HSD11B1 879/4885ERN1 3124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.